Skip to content
by Legal Desire
27 November 2023

Hogan Lovells advises Fresenius Kabi on divestment of Halden plant in Norway

Advising firms

Deal team

17 lawyers named
LawyerFirmSeniorityPracticeOffice
Torsten Rosenboom Lead Hogan Lovells Partner Corporate/ M&A Frankfurt
Dr Christoph Naumann Hogan Lovells Partner Corporate/ M&A Not stated
Andreas Thun Hogan Lovells Counsel Corporate/ M&A Not stated
Dr Marius Rothermund Hogan Lovells Senior associate Corporate/ M&A Not stated
Matthias Murr Hogan Lovells Senior associate Corporate/ M&A Not stated
Dr Mike Karl Schmidt Hogan Lovells Associate Corporate/ M&A Not stated
Hannah Wohlfarth Hogan Lovells Associate Corporate/ M&A Not stated
Nicolas Persch Hogan Lovells Other Corporate/ M&A Not stated
Melisa Gürsoy Hogan Lovells Other Corporate/ M&A Not stated
Bianca Engelmann Hogan Lovells Partner Finance Not stated
Arne Thiermann Hogan Lovells Partner Life Sciences Not stated
Dr Benjamin Goehl Hogan Lovells Senior associate Life Sciences Not stated
Marcus Kaiser Hogan Lovells Senior associate Life Sciences Not stated
Caroline Schmalenbach Hogan Lovells Associate Life Sciences Not stated
Dr. Marc Schweda Hogan Lovells Partner Antitrust Not stated
Dr Jan-Christoph Rudowicz Hogan Lovells Counsel Antitrust Not stated
Dr Sabrina Gäbeler Hogan Lovells Counsel Employment Not stated

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Fresenius Kabi AG
Counterparties
HP Halden Pharma AS (Buy-side)
Prange Group (Buy-side)